Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market Information
Our common stock trades on the NASDAQ Global Market under the symbol “KRT.” Our common stock commenced public trading on April 15, 2021.
Holders of Common Stock
As of March 10, 2026, we had 2 stockholders of record of our common stock. A substantially greater number of holders of our common stock are “street name” or beneficial holders, whose shares are held by banks, brokers and other financial institutions.
Dividends
On August 7, 2023, our Board of Directors approved a quarterly cash dividend policy, which we have paid on a regular basis since then. Continuation of the quarterly dividend will be at the discretion of our Board of Directors and will depend on a number of factors, including our financial condition, results of operations, capital requirements, contractual restrictions, general business conditions, and other factors that our Board of Directors may deem relevant. There are currently no restrictions on our present ability to pay dividends to stockholders of our common stock, other than those prescribed by Delaware law.
Securities Authorized for Issuance Under Equity Compensation Plans
The following table provides information as of December 31, 2025 with respect to all of our compensation plans under which equity securities are authorized for issuance:
Number of Securities
To Be Issued Upon Exercise of Outstanding Options, Warrants and Rights Weighted Average Exercise Price of Outstanding Options, Warrants and Rights Number of Securities Remaining Available for Future Issuance
Equity compensation plans approved by stockholders 330,967 (1)
$18.56 (2)
1,277,517
Total 330,967 $18.56 1,277,517
(1) This amount consists of (i) 43,500 shares of our common stock subject to unvested restricted stock units granted under the Plan, and (ii) 287,467 shares subject to stock options granted under the Plan.
(2) This number reflects the weighted-average exercise price of outstanding options and has been calculated exclusive of outstanding restricted stock unit awards issued under the Plan.
Sales of Unregistered Securities
We did not sell any unregistered equity securities during the year ended December 31, 2025.
Issuer Purchases of Equity Securities
The following table sets forth information regarding our purchases of shares of our common stock during the fourth quarter of fiscal year 2025:
33
Period
Total Number of Shares Purchased
Weighted-Average Price Paid per Share (1)
Total Number of Shares Purchased as Part of Publicly Announced Program
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program (1)
(in thousands)
October 1, 2025 - October 31, 2025
— — — —
November 1, 2025 - November 30, 2025
107,555 $ 21.64 107,555 $ 12,673
December 1, 2025 - December 31, 2025
29,819 $ 22.09 29,819 $ 12,014
Total 137,374 137,374
(1) On November 5, 2025, the Company announced that our Board of Directors approved a share repurchase program (the "Share Repurchase Program"), authorizing us to repurchase up to $15.0 million of our common stock. The Share Repurchase Program has no set expiration date, and may be suspended, modified or discontinued at any time, and we have no obligation to repurchase any amount of our common stock under the program. All dollar amounts presented in the table above and in this report related to our share repurchases and our share repurchase authorizations exclude the impact of the excise tax imposed on share repurchases pursuant to the Inflation Reduction Act of 2022. See Note 10 - Stockholders' Equity in the Notes to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for further information related to our share repurchases.
ITEM 6. [RESERVED]
34